Skip to main content
SpringerLink
Log in

Prosexual drugs: Empirical status of the “new aphrodisiacs”

  • Published:
Archives of Sexual Behavior Aims and scope Submit manuscript

Abstract

The search for an effective aphrodisiac has been a perennial pursuit of most societies throughout history. In the past decade, attention has focused increasingly on the prosexual effects of oral pharmacological agents with central neurotransmitter actions. The role of various dopaminergic, adrenergic, and serotonergic agents, in particular, has been intensively investigated in both human and animal studies. Some of these drugs have been considered for their potential role in the treatment of sexual dysfunction, while others have contributed to our understanding of basic neurophysiological processes in sexual arousal. This review provides a critical evaluation of current laboratory and clinical research on the “new aphrodisiacs,” including studies in both patient populations and normal volunteers. Several conceptual and methodological problems are addressed, such as the definition and measurement of sexual response, the need to separate specific and nonspecific drug effects on sexual response, and the lack of studies in women. Although no single drug has proven to be clinically safe and reliably effective for human use, several promising candidates have been identified. Overall, research on prosexual drugs has contributed significantly to our understanding of basic mechanisms in sexual response, as well as providing new treatment options for common sexual disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abel, E. L. (1985)Psychoactive Drugs and Sex Plenum Press, New York.

    Google Scholar 

  • Agmo, A., and Paredes, R. (1985). GABA-ergic drugs and sexual behavior in the male rat.Eur. J. Pharmacol. 112: 371–378.

    PubMed  Google Scholar 

  • Ahlenius, S., Larsson, K., and Arvidsson, L. E. (1989). Effects of stereoselective 5-HT-1A agonists on male rat sexual behavior.Pharmacol. Biochem. Behav. 33: 691–695.

    PubMed  Google Scholar 

  • Althof, S. E., and Turner, L. A. (1992). Self-injection therapy and external vacuum devices in the treatment of erectile dysfunction. In Rosen, R. C. and Leiblum, S. R. (eds.),Erectile Disorders: Assessment and Treatment, Guilford, New York.

  • Angrist, B., and Gershon, B. (1976). Clinical effects of amphetamine and L-dopa on sexuality and aggression.Comprehen. Psychiat. 17: 715–722.

    Google Scholar 

  • Bancroft, J. (1989).Human Sexuality and its Problems Churchill Livingstone, New York.

    Google Scholar 

  • Bansal, S. (1988). Sexual dysfunction in hypertensive men: A critical review of the literature.Hypertension 12: 1–10.

    PubMed  Google Scholar 

  • Beach, F. A. (1942). Analysis of factors involved in the arousol, maintenance, and manifestation of sexual excitement in male animals.Psychosom. Med. 4: 173–198.

    Google Scholar 

  • Benkert, O., Crombach, G., and Kockott, G. (1972). Effect of L-dopa on sexually impotent patients.Psychopharmacologia 23: 91–95.

    PubMed  Google Scholar 

  • Bitran, D., and Hull, E. M. (1987). Pharmacological analysis of male rat sexual behavior.Neurosci. Biobehav. Rev. 11: 365–389.

    PubMed  Google Scholar 

  • Bowers, M. B., Van Woert, M., and Davis, L. (1970). Sexual behavior during L-dopa treatment for Parkinsonism.Am. J. Psychiat. 127: 1691–1693.

    Google Scholar 

  • Brown, E., Brown, G. M., Kofman, O., and Quarrington, B. (1978). Sexual function and affect in Parkinson men treated with L-dopa.Am. J. Psychiat. 135: 1552–1555.

    PubMed  Google Scholar 

  • Brown, R. G., Jahanshahi, M., Quinn, N., and Marsden, C. D. (1990). Sexual function in patients with Parkinson's disease and their partners.J. Neurol. Neurosurg. Psychiat. 53: 480–486.

    PubMed  Google Scholar 

  • Buffum, J. (1982). Pharmacosexology: The effects of drugs on sexual function.J. Psychoact. Drugs 14: 5–44.

    Google Scholar 

  • Buffum, J. (1988). Substance abuse and high-risk sexual behavior.J. Psychoact. Drugs 20: 165–168.

    Google Scholar 

  • Carani, C., Zini, D., Baldini, A., Della Cassa, L., Ghizzani, A., and Marrama, P. (1990). Effects of androgen treatment in impotent men with normal and low levels of free testosterone.Arch. Sex. Behav. 19: 223–234.

    PubMed  Google Scholar 

  • Chambers, K. C., and Phoenix, C. H. (1989). Apomorphine, deprenyl, and yohimbine fail to increase sexual behavior in rhesus males.Behav. Neurosci. 103: 816–823.

    PubMed  Google Scholar 

  • Clark, J. T., Smith, E. R., and Davidson, J. M. (1984). Enhancement of sexual motivation in male rats by yohimbine.Science 225: 847–849.

    PubMed  Google Scholar 

  • Clark, J. T., Smith, E. R., and Davidson, J. M. (1985). Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats.Neuroendocrinology 41: 36–43.

    PubMed  Google Scholar 

  • Crenshaw, T. L., Goldberg, J. P., and Stern, W. C. (1987). Pharmacologic modification of psychosexual dysfunction.J. Sex Marital Ther. 13 239–253.

    PubMed  Google Scholar 

  • Crowe, L. C., and George, W. H. (1989). Alcohol and human sexuality: Review and integration.Psychol. Bull. 105: 374–386.

    PubMed  Google Scholar 

  • Danjou, P., Alexandre, L., Warot, D., Lacomblez, L., and Puech, A. J. (1988). Assessment of erectogenci properties of apomorphine and yohimbine in man.Br. J. Clin. Pharmacol. 26: 733–739.

    PubMed  Google Scholar 

  • Davidson, J. M., and Rosen, R. C. (1992). Hormonal determinants of erectile function. In Rosen, R. C., and Leiblum, S. R. (eds.),Erectile Disorders: Assessment and Treatment, Guilford, New York.

  • Dornan, W. A., and Malsbury, C. W. (1989). Neuropeptides and male sexual behavior.Neurosci. Biobehav. Rev. 13: 1–15.

    PubMed  Google Scholar 

  • Everitt, B. J. (1990). Sexual motivation: A neural and behavioral analysis of the mechanisms underlying appetitive and copulatory responses of male rats.Neurosci. Biobehav. Rev. 14: 217–232.

    PubMed  Google Scholar 

  • Everitt, B. J., and Bancroft, J. (1991). Of rats and men: The comparative approach to male sexuality.Ann. Rev. Sex Res. 2: 77–118.

    Google Scholar 

  • Foreman, M. M., Hall, J. L., and Love, R. L. (1989). The role of the 5-HT-2 receptor in the regulation of sexual performance of male rats.Life Sci. 45: 1263–1270.

    PubMed  Google Scholar 

  • Foreman, M. M., and Wernicke, J. F. (1990). Approaches for the development of oral drug therapies for erectile dysfunction.Semin. Urol. 8: 107–112.

    PubMed  Google Scholar 

  • Freed, E. (1983). Increased sexual function with nomifensine.Med. J. Austral. 1: 551.

    Google Scholar 

  • Gartrell, N. (1986). Increased libido in women receiving trazodone.Am. J. Psychiat. 143: 781–782.

    PubMed  Google Scholar 

  • Ghadirian, A. M., Chouinard, G., and Annable, L. (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.J. Nerv. Ment. Dis. 170: 463–467.

    PubMed  Google Scholar 

  • Gross, M. D. (1982). Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants.Am. J. Psychiat. 139: 1193–1194.

    PubMed  Google Scholar 

  • Haslam, M. (1989). Drug treatment of impotence. Presented at the 8th World Congress of Psychiatry. Athens, Greece.

  • Herman, J. B., Brotman, A. W., Pollack, M. H., Falk, W. E., Biederman, J., and Rosenbaum, J. F. (1990). Fluoxetine-induced sexual dysfunction.J. Clin. Psychiat. 51: 25–27.

    Google Scholar 

  • Hull, E. M., Bitran, D., Pehek, E. A., Warner, R. K., and Band, L. C., (1984). Intracerebral infusions of oxotremorine affect male sex behavior.Soc. Neurosci. Abstr. 10: 822.

    Google Scholar 

  • Hull, E. M., Bitran, D., Pehek, E. A., Warner, R. K., Band, L. C., and Holmes, G. M. (1986). Dopaminergic control of male sexual behavior in rats: Effects of an intracerebrally-infused agonist.Brain Res. 370: 73–81.

    PubMed  Google Scholar 

  • Hyyppa, M., Falck, S. C., and Rinne, U. K. (1975). Is L-dopa an aphrodisiac in patients with Parkinson's disease? In Sandler, M., and Gessa, G. L. (eds),Sexual Behavior Pharmacology and Biochemistry Plenum Press, New York.

    Google Scholar 

  • Hyyppa, M., Rinne, U. K., and Sonninen, V. (1970). The activating effect of L-dopa treatment on sexual functions and its experimental background.Acta Neurol. Scand. 46(Supp. 43): 223–224.

    PubMed  Google Scholar 

  • Jeanty, P., Van den Kerchove, M., Lowenthal, A., and DeBruyne, H. (1984). Pergolide therapy in Parkinson's disease.J. Neurol. 231: 148–152.

    PubMed  Google Scholar 

  • Kaplan, H. S. (1979).Disorders of Sexual Desire New York, Brunner/Mazel.

    Google Scholar 

  • Klassen, A. D., and Wilsnack, S. C. (1986). Sexual experience and drinking among women in a U.S. national survey.Arch. Sex. Behav. 15: 363–392.

    PubMed  Google Scholar 

  • Klein, K. B., Mendels, J., and Lief, H. I. (1987). Drug treatment of patients with inhibited sexual desire: A controlled clinical trial. Presented at the SSTAR annual meeting, New Orleans.

  • Kline, M. D. (1989). Fluoxetine and anorgasmia.Am. J. Psychiat. 146: 804–805.

    PubMed  Google Scholar 

  • Kostis, J. B., Rosen, R. C., Holzer, B. C., Randolph, C., Taska, L. S., and Miller, M. H. (1990). CNS effects of centrally-active antihypertensive agents: A prospective, placebo-controlled study of sleep, mood state, cognitive and sexual function in hypertensive males.Psychopharmacology 102: 163–170.

    PubMed  Google Scholar 

  • Kwong, L. L., Smith, E. R., Davidson, J. M., and Peroutka, S. J. (1986). Differential interactions of “prosexual” drugs with 5-hydroxytryptamine1A and alpha-2 adrenergic receptors.Behav. Neurosci. 100: 664–668.

    PubMed  Google Scholar 

  • Lal, S., Ackman, D., Tharundayil, J. X., Kiely, M. E., and Etienne, P. (1984). Effects of apomorphine, a dopamine receptor against, on penile tumescence in normal subjects.Prog. Neurol. Psychopharmacol. Biol. Psychiat. 8: 695–699.

    Google Scholar 

  • Lal, S., Laryea, E., Tharundayil, J. X., Vasavan Nair, N. P., Negrette, J., Ackman, D., Blundell, P., and Gardiner, R. (1987). Apomorphine induced penile tumescence in impotent patients—preliminary findings.Prog. Neurol. Psychopharmacol. Biol. Psychiat. 11: 235–242.

    Google Scholar 

  • Lal, S., Rios, O., and Thavundayil, J. X. (1990). Treatment of impotence with trazodone: A case report.J. Urol. 143: 819–820.

    PubMed  Google Scholar 

  • Lal, S., Tesfaye, Y., Tharundayil, J. X., Thompson, T. R., Kiely, M. E., Vasavan, N. P., Grassino, A., and Dubrovsky, B. (1989). Apomorphine: Clinical studies on erectile impotence and yawning.Prog. Neurol. Psychopharmacol. Biol. Psychiat. 13: 329–339.

    Google Scholar 

  • Lee, R. L., Smith. E. R., Mas, M., and Davidson, J. M. (1990). Effects of intrathecal administration of 8-OH-DPAT on genital reflexes and mating behavior in male rats.Physiol. Behav. 47: 665–669.

    PubMed  Google Scholar 

  • Levine, S. B. (1988). Intrapsychic and individual aspects of sexual desire. In Leiblum, S. R., and Rosen, R. C. (eds.),Sexual Desire Disorders, Guilford, New York.

  • Margolis, R., Prieto, P., Stein, L., and Chinn, S. (1971). Statistical summary of 10,000 male cases using afrodex in the treatment of impotence.Curr. Ther. Res. 13: 616–621.

    PubMed  Google Scholar 

  • Masters, W. H., and Johnson, V. E. (1966).Human Sexual Response. Boston: Little Brown.

    Google Scholar 

  • McLean, J. D., Forsythe, R. G., and Kapkin, I. A. (1983). Unusual side effects of clomipramine associated with yawning.Can. J. Psychiat. 28: 569–570.

    Google Scholar 

  • Modell, J. G. (1989). Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration.J. Clin. Psychopharmacol. 9: 63–65.

    PubMed  Google Scholar 

  • Monteiro, W. O., Noshirvani, H. F., Marks, I. M., and Lelliott, P. T. (1987). Anorgasmia from clomipramine in obsessive-compulsive disorder: A controlled trial.Br. J. Psychiat. 151: 107–112.

    Google Scholar 

  • Morales, A., Condra, M., Owen, J. A., Surridge, D. H., Fenemore, J., and Harris, C. (1987). Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial.J. Urol. 137: 1168–1172.

    PubMed  Google Scholar 

  • Morales, A., Surridge, D. H., and Marshall, P. G. (1981). Yohimbine for treatment of impotence in diabetes.New Engl. J. Med. 305: 1221.

    Google Scholar 

  • Othmer, E., and Othmer, S. C. (1987). Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder.J. Clin. Psychiat. 48: 201–203.

    Google Scholar 

  • Pfaus, J. G., and Gorzalka, B. (1987). Opioids and sexual behavior.Neurosci. Biobehav. Rev. 11: 1–34.

    PubMed  Google Scholar 

  • Pfaus, J. G., and Phillips, A. G. (1989). Differential effects of dopamine receptor antagonists in sexual behavior of male rats.Psychopharmacology 98: 363–368.

    PubMed  Google Scholar 

  • Poloniecki, J., and Hamilton, M. (1985). Subjective costs of antihypertensive treatment.Hum. Toxicol. 4: 287–291.

    PubMed  Google Scholar 

  • Ricaurte, G. A., Molliver, M. E., Martello, M. B., Katz, J. L., Wilson, M. A., Martello, A. L., and Wilson, M. A. (1991). Dexfenfluramine neurotoxicity in brains of nonhuman primates.Lancet 338: 1487–1488.

    PubMed  Google Scholar 

  • Rosen, R. C. (1991). Alcohol and drug effects on sexual response: Human experimental and clinical studies.Ann. Rev. Sex Res. 2: 119–179.

    Google Scholar 

  • Rosen, R. C., and Beck, J. G. (1988). Patterns of sexual arousal:Psychophysiological Processes and Clinical Applications, Guilford, New York.

  • Rosen, R. C., and Hall, E. (1984).Sexuality Random House, New York.

    Google Scholar 

  • Rosen, R. C., and Leiblum, S. R. (1989). Assessment and treatment of desire disorders. In Leiblum, S. R., and Rosen, R. C. (eds.),Principles and Practice of Sex Therapy: Update for the 1990's, Guilford, New York.

  • Scatton, B., Zivkovic, B., and Dedek, J. (1980). Antidopaminergic properties of yohimbine.J. Pharmacol. Exp. Ther. 215: 494–499.

    PubMed  Google Scholar 

  • Scher, M., Krieger, J., and Jurgens, S. (1983). Trazodone and priapism.Am. J. Psychiat. 140: 1362–1363.

    PubMed  Google Scholar 

  • Schiavi, R. C. (1990). Chronic alcoholism and male sexual dysfunction.J. Sex Mar. Ther. 16: 23–33.

    Google Scholar 

  • Schlatter, E. K., and Lal, S. (1972). Treatment of alcoholism using Dent oral apomorphine method.Quart. J. Stud. Alc. 33: 430–436.

    Google Scholar 

  • Segraves, R. T. (1987). Reversal by bethanacol of impramine-induced ejaculatory dysfunction.Am. J. Psychiat. 144: 1243–1244.

    Google Scholar 

  • Segraves, R. T. (1989). Effects of psychotropic drugs on human erection and ejaculation.Arch. Gen. Psychiat. 46: 275–284.

    PubMed  Google Scholar 

  • Segraves, R. T., Bari, M., Segraves, K., and Spirmak, P. (1991). Effect of apomorphine on penile tumescence in men with psychogenic impotence.J. Urol. (in press).

  • Smith, P. J., and Talbert, R. L. (1986). Sexual dysfunction with antihypertensive and antipsychotic agents.Clin. Pharm. 5: 373–384.

    PubMed  Google Scholar 

  • Sobotka, J. J. (1969). An evaluation of Afrodex in the management of male impotency: A double-blind crossover study.Curr. Ther. Res. 11: 87–94.

    PubMed  Google Scholar 

  • Sonda, L. P. Mazo, R., and Chancellor, M. B. (1990). The role of yohimbine for the treatment of erectile impotence.J. Sex Marital Ther. 16: 15–22.

    PubMed  Google Scholar 

  • Sorscher, S. M., and Dilsaver, S. C. (1986). Anti-depressant induced sexual dysfunction in men: Due to cholinergic blockade?J. Clin. Psychopharmacol. 6: 53–55.

    PubMed  Google Scholar 

  • Steers, W. D. (1990). Neural control of penile erection.Sem. Urol. 8: 66–79.

    Google Scholar 

  • Steers, W. D., and DeGroat, W. C. (1990). Effects of m-chlorophenyl-piperazine on penile and bladder function in rats.Am. J. Physiol. 257: 1441–1449.

    Google Scholar 

  • Stevenson, R. W. D., and Solyom, L. (1990). The aphrodisiac effect of fenfluramine: Two case reports of a possible side effect to the use.J. Clin. Psychiat. 10: 69–71.

    Google Scholar 

  • Sullivan, G. (1988). Increased libido in three men treated with Trazodone.J. Clin. Psychiat. 49: 202–203.

    Google Scholar 

  • Susset, J. G., Tessier, C. D., Wincze, J., Bansal, S., Malhotra, C., and Schwacha, M. G. (1989). Effect of yohimbine hydrochloride on erectile impotence: A double-blind study.J. Urol. 141: 1360–1363.

    PubMed  Google Scholar 

  • Tennent, G., Bancroft, J., and Cass, J. (1974). The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine, and placebo.Arch. Sex. Behav. 3: 261–271.

    PubMed  Google Scholar 

  • Tiefer, L. (1991). Historical, scientific, clinical and feminist criticisms of “the human sexual response cycle” model.Ann. Rev. Sex Res. 2: 1–24.

    Google Scholar 

  • Uitti, R. J., Tanner, C. M., Rajput, A. H., Goetz, C. G., Klawans, H. L., and Thiessen, B. (1989). Hypersensitivity with antiparkinsonian therapy.Clin. Neuropharmacol. 12: 375–383.

    PubMed  Google Scholar 

  • Warner, M. D., Peabody, C. A., and Whiteford, H. A. (1987). Trazodone and priapism.J. Clin. Psychiat. 48: 244–245.

    Google Scholar 

  • Ware, J. C., Pittard, J. T., Nadig, P. W., Morrison, J. L., and Quinn, J. B. (1987). Trazadone: Its effects on nocturnal penile tumescence.Sleep Res. 16: 157.

    Google Scholar 

  • Ware, J. C., Rose, V., and McBrayer, R. (1991). The effects of nefazodone, trazodone, buspirone, and placebo on sleep and sleep related penile erections (NPT) in normal subjects.Sleep Res. 20: 91.

    Google Scholar 

  • Wilson, G. T. (1981). The effects of alcohol on human sexual behavior.Adv. Substance Abuse 2: 1–40.

    Google Scholar 

  • Yager, J. (1986). Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: Case report.J. Clin. Psychiat. 47: 210–211.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Medicine and Dentistry of New Jersey—Robert Wood Johnson Medical School, 675 Hoes Lane, 08854-5635, Piscataway, New Jersey, USA

    Raymond C. Rosen Ph.D.

  2. School of Medicine, State University of New York at Buffalo, USA

    Adam Keller Ashton M.D.

Authors
  1. Raymond C. Rosen Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam Keller Ashton M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosen, R.C., Ashton, A.K. Prosexual drugs: Empirical status of the “new aphrodisiacs”. Arch Sex Behav 22, 521–543 (1993). https://doi.org/10.1007/BF01543299

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01543299

Key words

Search

Navigation